LifeTech Scientific Corpo... (LFTSF)
LifeTech Scientific Statistics
Share Statistics
LifeTech Scientific has 4.4B shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 4.4B |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.69B |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 25.62 and the forward PE ratio is null. LifeTech Scientific's PEG ratio is -1.1.
| PE Ratio | 25.62 |
| Forward PE | n/a |
| PS Ratio | 5.32 |
| Forward PS | n/a |
| PB Ratio | 2 |
| P/FCF Ratio | 53.8 |
| PEG Ratio | -1.1 |
Enterprise Valuation
LifeTech Scientific has an Enterprise Value (EV) of 5.77B.
| EV / Sales | 4.56 |
| EV / EBITDA | 22.78 |
| EV / EBIT | 13.81 |
| EV / FCF | 46.07 |
Financial Position
The company has a current ratio of 2.9, with a Debt / Equity ratio of 0.
| Current Ratio | 2.9 |
| Quick Ratio | 2.27 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.07 |
| Interest Coverage | 530.86 |
Financial Efficiency
Return on Equity is 7.81% and Return on Invested Capital is 5.97%.
| Return on Equity | 7.81% |
| Return on Assets | 5.61% |
| Return on Invested Capital | 5.97% |
| Revenue Per Employee | $908.37K |
| Profits Per Employee | $188.7K |
| Employee Count | 1,395 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 0.56 |
Taxes
| Income Tax | 68.09M |
| Effective Tax Rate | 38.78% |
Stock Price Statistics
The stock price has increased by -1.5% in the last 52 weeks. The beta is 1.23, so LifeTech Scientific's price volatility has been higher than the market average.
| Beta | 1.23 |
| 52-Week Price Change | -1.5% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 30.9 |
| Average Volume (20 Days) | 53 |
Income Statement
In the last 12 months, LifeTech Scientific had revenue of 1.27B and earned 263.24M in profits. Earnings per share was 0.06.
| Revenue | 1.27B |
| Gross Profit | 995.64M |
| Operating Income | 383.28M |
| Net Income | 263.24M |
| EBITDA | 253.46M |
| EBIT | 176.3M |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 979.31M in cash and 9.3M in debt, giving a net cash position of 970.02M.
| Cash & Cash Equivalents | 979.31M |
| Total Debt | 9.3M |
| Net Cash | 970.02M |
| Retained Earnings | 1.65B |
| Total Assets | 4.82B |
| Working Capital | 1.39B |
Cash Flow
In the last 12 months, operating cash flow was 418.05M and capital expenditures -292.69M, giving a free cash flow of 125.36M.
| Operating Cash Flow | 418.05M |
| Capital Expenditures | -292.69M |
| Free Cash Flow | 125.36M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 78.57%, with operating and profit margins of 30.25% and 20.77%.
| Gross Margin | 78.57% |
| Operating Margin | 30.25% |
| Pretax Margin | 13.86% |
| Profit Margin | 20.77% |
| EBITDA Margin | 20% |
| EBIT Margin | 30.25% |
| FCF Margin | 9.89% |
Dividends & Yields
LFTSF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 3.9% |
| FCF Yield | 1.86% |
Analyst Forecast
Currently there are no analyst rating for LFTSF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.74 |
| Piotroski F-Score | 5 |